Stock Price, News, Quote and Profile of LANTHEUS HOLDINGS INC(NASDAQ:LNTH) stock

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

LANTHEUS HOLDINGS INC

NASDAQ:LNTH (11/22/2024, 8:00:00 PM)

After market: 90.52 0 (0%)

90.52

+3.2 (+3.66%)

Chartmill TA Rating

Chartmill Setup Rating

Sector

GICS SectorHealth Care

GICS IndustryHealth Care Equipment & Supplies

GICS SubIndustry

Chartmill FA Rating

Valuation

Growth

Profitability

Health

Dividend

Chartmill High Growth Momentum

EPS Q2Q%

Sales Q2Q%

CRS

6 Month15.72%

Overview

Earnings (Last)

Earnings (Next)

Ins Owners

Inst Owners

Market Cap6.29B

PE13.04

Fwd PE12.6

Dividend YieldN/A

Analysts

IPO

Stock Screener Links

GICS Sector Stock Screener

Find competitors from the same sector on the USA

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

Company Profile

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The company is headquartered in North Billerica, Massachusetts and currently employs 834 full-time employees. The company went IPO on 2015-06-25. The firm classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Its Radiopharmaceutical Oncology diagnostics and therapeutic candidates help healthcare professionals (HCPs) find, fight, and follow cancer, with a focus in prostate cancer. Its pipeline also includes breast and other cancers. Its Precision Diagnostic products assist HCPs to find and follow diseases, with a focus in cardiology. Its Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma solutions platforms. Its commercial products include PYLARIFY, DEFINITY, Ga-DOTA-RM2, and others. Its pipeline includes B amyloid positron emission tomography (PET) imaging agent, NAV-4694, also known as F18-flutafuranol.

Company Info

LANTHEUS HOLDINGS INC

331 Treble Cove Rd

North Billerica MASSACHUSETTS 01862

P: 19786718001

CEO: Mary Anne Heino

Employees: 834

Website: https://www.lantheus.com/

LNTH News

3 days ago - The Motley FoolWhy Lantheus Holdings Stock Won Big on Wednesday

4 days ago - Lantheus Holdings, Inc.Lantheus Announces Share Repurchase Program

BEDFORD, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading...

11 days ago - Lantheus Holdings, Inc.Lantheus to Present at the Jefferies London Healthcare Conference

BEDFORD, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company...

12 days ago - ChartmillNASDAQ:LNTH stands out as a stock that provides good value for the fundamentals it showcases.

LANTHEUS HOLDINGS INC (NASDAQ:LNTH): good value for what you're paying.

LANTHEUS HOLDINGS INC (LNTH)

Nasdaq Stock Screener

USA Stock Screener